A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse Kidney Events (MAKE)

  • Kidney Disorder
  • Acute Kidney Injury
Please note that the recruitment status of the trial at your site may differ from the overall study status because some study sites may recruit earlier than others.
Trial Status:

Not yet recruiting

This trial runs in
N/A
Trial Identifier:

NCT06602453 2024-513125-23-00 GC45428

      Show trial locations

      The source of the below information is public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc.. It has been summarised and edited into simpler language. For more information about this clinical trial see the For Expert tab on the specific ForPatients page or follow these links to https://clinicaltrials.gov and/or https://euclinicaltrials.eu and/or https://www.isrctn.com.

      The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc., and has not been edited.

      Results Disclaimer

      Trial Summary

      The aim of this study is to evaluate the efficacy and safety of GDC-8264 compared with placebo in participants undergoing cardiac surgery who are determined to be at moderate to high risk of developing AKI and subsequent MAKE at 90 days after surgery (MAKE90). The study will be performed in two parts- Part 1 and Part 2.

      Genentech, Inc. Sponsor
      Phase 2 Phase
      NCT06602453, GC45428, 2024-513125-23-00 Trial Identifier
      GDC-8264, Placebo Treatments
      Acute Kidney Injury Condition
      Official Title

      A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury and Major Adverse Kidney Events

      Eligibility Criteria

      All Gender
      ≥40 Years Age
      No Healthy Volunteers
      Inclusion Criteria
      • One of the following non-emergent cardiac surgery types that requires cardiopulmonary bypass (CPB) to be done in one procedure rather than separate procedures: Isolated Coronary Artery Bypass Grafting (CABG); Isolated surgical Aortic Valve Replacement (AVR), Mitral Valve Replacement (MVR), Mitral Valve repair (MVr); Combined CABG+AVR, CABG+MVR, CABG+MVr, AVR+MVR, AVR+MVr
      • At least one or at least two of the following AKI risk factors, depending on the type of surgery: age > 70 years, history of CKD with eGFR < 60 milliliters/ minutes/ 1.73 meter square (ml/min/1.73 m^2) within the last 6 months, diabetes (type 1 or type 2) requiring at least one oral hypoglycemic agent or insulin, history of chronic obstructive pulmonary disease (COPD) requiring medical therapy, left ventricular ejection fraction (LVEF) < 40%, preoperative anemia {hemoglobin <10 milligrans/ deciliters (mg/dL)}
      • Stable kidney function with no known episodes of AKI within 2 weeks of screening
      Exclusion Criteria
      • Need for renal replacement therapy (peritoneal dialysis or hemodialysis)
      • Need for intra-aortic balloon pump, temporary mechanical circulatory support, or extracorporeal membrane oxygenation prior to scheduled surgery
      • Presence of a durable left ventricular assist device
      • Emergent cardiac surgery
      • Need for concurrent aortic surgery or repair of congenital heart defects
      • Heart transplant
      • Transcatheter valve replacements
      • Hypotension or shock requiring hospital admission
      • Cardiopulmonary resuscitation
      • eGFR < 20 mL/min/1.73 m^2
      • Heart failure with ejection fraction < 20%, or episode of decompensated heart failure requiring intervention within 2 weeks of screening
      • History of kidney transplant or only one kidney (due to donation)

      For the latest version of this information please go to www.forpatients.roche.com

       

      Related Trials

      Use our search to find other trials on ForPatients in related disease areas.

      Acute Kidney Injury

      Clinical Research Explained

      Information about what clinical trials and observational studies are. Understand why you might want to take part in clinical research and why diversity in clinical research is important.

      Find out now